Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
about
Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coliCell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epitheliumAntimicrobial polypeptides in host defense of the respiratory tractStudies on anticancer activities of antimicrobial peptidesLL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cellsThe peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surfaceDesign and Application of Antimicrobial Peptide ConjugatesPotential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesMechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin DSphingolipids and antimicrobial peptides: function and roles in atopic dermatitisThe Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal MucosaStructural and Functional Analysis of the Pro-Domain of Human Cathelicidin, LL-37High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptidesUltrashort cationic lipopeptides and lipopeptoids selectively induce cytokine production in macrophagesCathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulationA Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in FishesA PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides.The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study.Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection.Human antimicrobial peptides and proteinsActivities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model.Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia.HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.Comparative efficacy analysis of anti-microbial peptides, LL-37 and indolicidin upon conjugation with CNT, in human monocytesAntimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.Structural and functional analysis of horse cathelicidin peptides.Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri.Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptideBactericidal activity of mammalian cathelicidin-derived peptides.Regulation of the human cathelicidin antimicrobial peptide gene by 1α,25-dihydroxyvitamin D3 in primary immune cellsLL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalentsDying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensinsPositive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults.Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residuesExpression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways.
P2860
Q24529975-1E7B4E8E-D6D1-4E7B-BCEE-728469A077C8Q24537181-31E0DE1B-5D28-4380-9771-FCBC54B93480Q24551612-ED6E862D-D268-42DD-8D6E-73C51BF7E361Q24650885-CDE8BB23-0DA0-4806-A4E8-B556806084ABQ24675869-08F2620B-53E2-4AE9-BBCE-AF95BD21E450Q24680172-36990F5B-D2FB-4ECF-8BA1-1A5E8A740F64Q26749068-B17E2C31-007C-497E-B85E-AE5CC425BAB8Q26765450-09A16835-8694-44D3-BDD7-ED68CF89B4E3Q26781318-0F56848F-13B2-4495-AC81-4446FCA5CF9CQ26829596-FCCDEE76-DFAF-4115-B060-96CC26CF57C1Q27000032-CF3AAA91-1D90-4988-9BBF-86DDF2D76BD9Q27676356-03EB311F-1947-40CB-A702-4C4A4529D6A2Q27692605-099E9691-4F91-4BF7-9E2C-931B0978BCC5Q28478122-B768B968-F846-4EF2-A60A-BB1B59D5E7A7Q28485935-977206C7-7B8F-49EF-90C3-4A2076167183Q28534617-62544799-45B4-4B46-B1CD-B3504CDED358Q28553706-0FD25ECC-6820-418B-918C-FC9EC1E54329Q30453404-6A8724EA-DB31-4056-8804-D50D1BD7E146Q30486489-241B7B78-236A-418B-86D7-3BC7CDCE47CCQ30490685-7AAEC7E9-1595-4692-B35A-E1AC3FFEDB4BQ30564789-27EFB885-5989-433E-A42B-2257E2ECE81EQ33267198-3FDB4DF9-97D4-420A-931E-359AC7AC5DE4Q33591272-4107055F-A86E-4DC0-97A7-0DF057E60C9DQ33673156-574F3D13-C9F6-463B-9827-4AE35A03A21FQ33695688-9F15C1B5-4C48-490F-BFAD-5C4981A50919Q33703812-E3C39D59-D78B-4531-BA6B-A37BC8159FCBQ33753263-24BCFEC3-F835-42A1-BF26-89E597777ACEQ33753950-473FA75C-C4D6-44CC-9E4C-D7A88D7C7D5AQ33792343-8F181159-0C34-49BB-96E6-C83457F96FD2Q33883780-177552FF-90C4-4E8C-A5F2-B14663E0E949Q33981585-26F50F52-EA25-4F51-A585-92359A5B17A4Q33999607-B7F3E962-E985-445C-89D0-7AD5C3A93B28Q34000667-6F91E4E8-B11B-4C4E-9021-974D875898B7Q34004332-391C7BC4-1DA6-4116-BFC7-BB3BF7D0C77CQ34022785-B560D544-5BBB-4C93-86E5-90F9531F5BF4Q34058299-5E898EFC-A336-46BD-BA22-E1B9A9CCCA50Q34168249-C78E18C6-53AA-4D35-8879-79BB6BE5D39FQ34457000-894F9F2C-633C-4AF4-9843-CF3443409C0BQ34526677-447E47FC-DBC5-4BCA-BC86-8A6D8190C039Q34532741-0552F787-092A-46B1-9B34-A733CD9A6D1B
P2860
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@ast
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@en
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@nl
type
label
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@ast
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@en
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@nl
prefLabel
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@ast
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@en
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@nl
P2093
P2860
P3181
P1476
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
@en
P2093
P2860
P304
P3181
P407
P577
1995-04-01T00:00:00Z